Dr. Schowinsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aip Mail Stop F768
Aurora, CO 80045Phone+1 720-848-4411Fax+1 720-848-4454
Education & Training
- Johns Hopkins UniversityFellowship, Hematopathology, 2007 - 2008
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2003 - 2007
- Medical College of WisconsinClass of 2003
Certifications & Licensure
- CO State Medical License 2009 - 2025
- IA State Medical License 2008 - 2011
- PA State Medical License 2006 - 2008
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 8 citationsHigher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.Jonathan A Gutman, Amanda Winters, Andrew Kent, Maria Amaya, Christine McMahon
Haematologica. 2023-10-01 - 106 citationsReal-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemiaAmanda Winters, Jonathan A. Gutman, Enkhtsetseg Purev, Molly Nakic, Jennifer Tobin
Blood Advances. 2019-10-22 - 197 citationsMonocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.Shanshan Pei, Daniel A. Pollyea, Annika Gustafson, Brett M. Stevens, Mohammad Minhajuddin
Cancer Discovery. 2020-01-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: